• 1
    Vrouenraets BC,Kroon BBR,Nieweg OE,Thompson JF. Isolated limb perfusion for melanoma: results and complications. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London, UK: Martin Dunitz; 2004: 410-428.
  • 2
    Thompson JF,Hunt JA,Shannon KF,Kam PC. Frequency and duration of remission after isolated limb perfusion for melanoma. Arch Surg. 1997; 132: 903-907.
  • 3
    Vrouenraets BC,Nieweg OE,Kroon BB. Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg. 1996; 83: 1319-1328.
  • 4
    Vrouenraets BC,Klaase JM,Nieweg OE,Kroon BB. Toxicity and morbidity of isolated limb perfusion. Semin Surg Oncol. 1998; 14: 224-231.
  • 5
    Thompson JF,Kam PC. Current status of isolated limb infusion with mild hyperthermia for melanoma. Int J Hyperthermia. 2008; 24: 219-225.
  • 6
    Thompson JF,Waugh RC,Saw RPM,Kam PCA. Isolated limb infusion with melphalan for recurrent limb melanoma: a simple alternative to isolated limb perfusion. Reg Cancer Treat. 1994; 7: 188-192.
  • 7
    Thompson JF,Kam PC,Waugh RC,Harman CR. Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol. 1998; 14: 238-247.
  • 8
    Kroon HM,Moncrieff M,Kam PC,Thompson JF. Outcomes following isolated limb infusion for melanoma. A 14-year experience. Ann Surg. Oncol. 2008; 15: 3003-3013.
  • 9
    Lindner P,Thompson JF,De Wilt JH,Colman M,Kam PC. Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma. Eur J Surg Oncol. 2004; 30: 433-439.
  • 10
    Wong JH,Cagle LA,Kopald KH,Swisher SG,Morton DL. Natural history and selective management of in transit melanoma. J Surg Oncol. 1990; 44: 146-150.
  • 11
    Grunhagen DJ,van Etten B,Brunstein F, et al. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure. Ann Surg Oncol. 2005; 12: 609-615.
  • 12
    Noorda EM,Vrouenraets BC,Nieweg OE,van Geel AN,Eggermont AM,Kroon BB. Repeat isolated limb perfusion with TNF-α and melphalan for recurrent limb melanoma after failure of previous perfusion. Eur J Surg Oncol. 2006; 32: 318-324.
  • 13
    Thompson JF,Kam PC. Isolated limb infusion for melanoma: a simple but effective alternative to isolated limb perfusion. J Surg Oncol. 2004; 1:88: 81-83.
  • 14
    Wieberdink J,Benckhuysen C,Braat RP,van Slooten EA,Olthuis GA. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol. 1982; 18: 905-910.
  • 15
    Lai DTM,Ingvar C,Thompson JF. The value of monitoring serum creatine phosphokinase values following hyperthermic isolated limb perfusion for melanoma. Reg Cancer Treat. 1993; 6: 36-39.
  • 16
    World Health Organization. WHO Handbook for Reporting Results of Cancer Treatments (WHO Offset Pub. No. 48). Geneva, Switzerland: World Health Organization; 1979.
  • 17
    Mann HB,Whitney DR. On a test of whether 1 of 2 random variables is stochastically larger than the other. Ann Math Stat. 1947; 18: 50-60.
  • 18
    Kaplan L,Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1985; 53: 457-481.
  • 19
    Klaase JM,Kroon BBR,van Geel AN, et al. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. J Am Coll Surg. 1994; 178: 564-572.
  • 20
    Strobbe LJ,Nieweg OE,Kroon BBR. Carbon dioxide laser for cutaneous melanoma metastases: indications and limitations. Eur J Surg Oncol. 1997; 23: 435-438.
  • 21
    McKay A,Byrne DS. Recurrent limb melanoma: treatments other than isolated limb perfusion and infusion. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London, UK: Martin Dunitz; 2004: 443-448.
  • 22
    Klop WM,Vrouenraets BC,van Geel BN, et al. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. J Am Coll Surg. 1996; 182: 467-472.
  • 23
    Bartlett DL,Ma G,Alexander HR,Libutti SK,Fraker DL. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics. Cancer. 1997; 80: 2084-2090.
  • 24
    Lienard D,Ewalenko P,Delmotte JJ,Renard N,Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol. 1992; 10: 52-60.
  • 25
    Lejeune FJ. High dose recombinant tumour necrosis factor administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer. Eur J Cancer. 1995; 31A: 1009-1016.
  • 26
    Hoekstra HJ,Schraffordt Koops H,de Vries LGE,van Weerden TW,Oldhoff J. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment. Cancer. 1993; 72: 1224-1229.
  • 27
    Bonenkamp JJ,Thompson JF,de Wilt JH,Doubrovsky A,de Faria Lima R,Kam PC. Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence. Eur J Surg Oncol. 2004; 30: 1107-1112.
  • 28
    Vaglini M,Ammatuna M,Belli F, et al. Evaluation of a second isolated perfusion for melanoma of the limbs. Melanoma Res. 1993; 3: 100.
  • 29
    Moller MG,Lewis JM,Dessureault S,Zager JS. Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma. Int J Hyperther. 2008; 24: 275-289.
  • 30
    Thompson JF,Kam PCA,de Wilt JHW,Lindner P. Isolated limb infusion for melanoma. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London, UK: Martin Dunitz; 2004: 429-437.
  • 31
    Sanki A,Kam PCA,Thompson JF. Long-term results of hyperthermic, isolated limb perfusion for melanoma. Ann Surg. 2007; 4: 591-596.
  • 32
    Lejeune FJ,Lienard D,el Douaihy M,Seyedi JV,Ewalenko P. Results of 206 isolated limb perfusions for malignant melanoma. Eur J Surg Oncol. 1989; 15: 510-519.
  • 33
    Feldman AL,Alexander HRJr,Bartlett DL,Fraker DL,Libutti SK. Management of extremity recurrences after complete responses to isolated limb perfusion in patients with melanoma. Ann Surg Oncol. 1999; 6: 562-567.
  • 34
    Noorda EM,Takkenberg B,Vrouenraets BC, et al. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma. Ann Surg Oncol. 2004; 11: 491-499.
  • 35
    Thompson JF,De Wilt JHW. Isolated limb perfusion in the management of patients with recurrent limb melanoma: an important but limited role. Ann Surg Oncol. 2001; 8: 564-565.